ES2085888T3 - Composicion de vacuna. - Google Patents

Composicion de vacuna.

Info

Publication number
ES2085888T3
ES2085888T3 ES90300927T ES90300927T ES2085888T3 ES 2085888 T3 ES2085888 T3 ES 2085888T3 ES 90300927 T ES90300927 T ES 90300927T ES 90300927 T ES90300927 T ES 90300927T ES 2085888 T3 ES2085888 T3 ES 2085888T3
Authority
ES
Spain
Prior art keywords
animal
biological sample
taken
pathogen
vaccine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90300927T
Other languages
English (en)
Inventor
Elsa Nicole Theresia Meeusen
Malcolm Roy Brandon
Mark Douglas Gorrell
John Walker
Vernon Morrison Bowles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Meat Research Corp
Original Assignee
University of Melbourne
Meat Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne, Meat Research Corp filed Critical University of Melbourne
Application granted granted Critical
Publication of ES2085888T3 publication Critical patent/ES2085888T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1285—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Corynebacterium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

METODO PARA PRODUCIR AL MENOS UN ANTICUERPO CONTRA UN PATOGENO, QUE INCLUYE LOS PASOS DE OBTENER UNA MUESTRA BIOLOGICA DE UN EXTRACTO DEL AGENTE PATOGENO, DE UN ANIMAL INFECTADO E EN PELIGRO DE ESTARLO, AISLANDO CELULAS DE LA MUESTRA BIOLOGICA, CULTIVANDO LAS CELULAS IN VITRO EN UN MEDIO DE CULTIVO ADECUADO, Y CULTIVANDO LOS ANTICUERPOS PRODUCIDOS POR ESTA CELULAS. EL ANIMAL DEL QUE SE TOME LA MUESTRA BIOLOGICA PUEDE SER UN ANIMAL INMUNE, Y LA MUESTRA PUEDE TOMARSE POCO TIEMPO DESPUES DE QUE EL ANIMAL HAYA SIDO ATACADO POR LA INFECCION PATOGENICA.
ES90300927T 1989-02-01 1990-01-30 Composicion de vacuna. Expired - Lifetime ES2085888T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ250489 1989-02-01
AUPJ250589 1989-02-01

Publications (1)

Publication Number Publication Date
ES2085888T3 true ES2085888T3 (es) 1996-06-16

Family

ID=25643621

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90300927T Expired - Lifetime ES2085888T3 (es) 1989-02-01 1990-01-30 Composicion de vacuna.

Country Status (15)

Country Link
EP (1) EP0381427B1 (es)
JP (1) JPH0387199A (es)
CN (1) CN1046188A (es)
AP (1) AP144A (es)
AT (1) ATE134386T1 (es)
BR (1) BR9000451A (es)
CA (1) CA2008808A1 (es)
DE (1) DE69025414T2 (es)
DK (1) DK0381427T3 (es)
ES (1) ES2085888T3 (es)
FI (1) FI900498A0 (es)
GR (1) GR3019065T3 (es)
IL (1) IL93234A (es)
NO (1) NO178893C (es)
NZ (1) NZ232279A (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639876A (en) * 1991-02-12 1997-06-17 Heska Corporation Nucleic acid molecules encoding novel parasitic helminth proteins
EP0694560A3 (en) * 1994-07-29 1998-08-12 American Cyanamid Company Production of antigens of Pasteurella
AU2012201538B2 (en) * 2000-11-29 2014-09-11 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens
AUPR177400A0 (en) * 2000-11-29 2000-12-21 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens
CN102716474B (zh) * 2012-06-27 2013-10-16 中国人民解放军军事医学科学院微生物流行病研究所 蛋白Rh054_01780在抗黑龙江立克次体的免疫保护中的应用
CN113016713B (zh) * 2021-03-03 2022-12-02 新疆医科大学第一附属医院 从犬粪中分离细粒棘球绦虫虫卵及体外孵化出六钩蚴的方法
CN114196642B (zh) 2021-11-10 2023-12-05 浙江大学杭州国际科创中心 谷氨酸脱氢酶变体及其在制备l-氨基酸中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
WO1983002896A1 (en) * 1982-02-17 1983-09-01 D'antonio, Lawrence, E. Method for the purification of parasite antigenic factors
EP0286405A3 (en) * 1987-04-08 1989-08-09 Synbiotics Corporation Method for the early selection of anti-idiotype-antibody internal images

Also Published As

Publication number Publication date
EP0381427B1 (en) 1996-02-21
BR9000451A (pt) 1991-01-15
AP144A (en) 1991-09-27
NZ232279A (en) 1991-11-26
NO178893C (no) 1996-06-26
DK0381427T3 (da) 1996-06-17
EP0381427A3 (en) 1991-07-31
NO900442L (no) 1990-08-02
NO900442D0 (no) 1990-01-31
DE69025414D1 (de) 1996-03-28
EP0381427A2 (en) 1990-08-08
NO178893B (no) 1996-03-18
IL93234A (en) 1997-08-14
FI900498A0 (fi) 1990-01-31
CA2008808A1 (en) 1990-08-01
AU640364B2 (en) 1993-08-26
DE69025414T2 (de) 1996-07-11
CN1046188A (zh) 1990-10-17
ATE134386T1 (de) 1996-03-15
AP9000165A0 (en) 1990-04-30
AU4903590A (en) 1990-10-11
GR3019065T3 (en) 1996-05-31
JPH0387199A (ja) 1991-04-11

Similar Documents

Publication Publication Date Title
Smyth Studies on tapeworm physiology: XI. In vitro cultivation of Echinococcus granulosus from the protoscolex to the strobilate stage
Kane et al. In vitro encystation of Giardia lamblia: large-scale production of in vitro cysts and strain and clone differences in encystation efficiency
AR053286A2 (es) Cultivo de celulas de una cepa derivada de una cepa progenitra de una especie de neospora, vacuna que las contiene, metodos para preparar dicho cultivo, metodo para preparar una vacuna con dicho cultivo, metodo para vacunar un mamifero con dicha vacuna y vacuna que comprende dichas celulas
ES2185811T3 (es) Metodo para detectar bacterias.
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
Meeusen et al. Exploiting natural immunity to helminth parasites for the development of veterinary vaccines
ES2065303T3 (es) Procedimiento de diagnosis y vacuna especifica.
Henle et al. A skin test for infectious hepatitis.
ES2142864T3 (es) Procedimiento y medio de cultivo para la obtencion de celulas infectadas por un virus asociado a la esclerosis en placas.
Hermodsson et al. Properties of bovine virus diarrhoea virus
ES2085888T3 (es) Composicion de vacuna.
Marciano-Cabral et al. Cytopathogenicity of Naegleria fowleri and Naegleria gruberi for established mammalian cell cultures
Jørgensen Indirect fluorescent antibody techniques for demonstration of trout viruses and corresponding antibody
ES2052699T3 (es) Vacuna contra la gripe.
Johnson et al. Factors affecting the sensitivity of replicating McCoy cells in the isolation and growth of chlamydia A (TRIC agents)
Sax et al. Use of rabbit serum in the cultivation of Plasmodium falciparum
ES2100893T3 (es) Procedimiento de preparacion de una vacuna o de un agente toxico.
Pindak et al. Acquisition and retention of viruses by Trichomonas vaginalis.
Stromberg et al. Ascaris suum: immunization with soluble antigens in the guinea pig
ES2084576T3 (es) Vacuna contra la coccidiosis.
ES2106032T3 (es) Vacuna para inmunizar gatos contra el desprendimiento de oocistos de toxoplasma.
Greig et al. Cultivation in tissue culture of an infectious agent from coital exanthema of cattle. A preliminary report
Ekless et al. Ichthyophthirius multifiliis: axenic isolation and short‐term maintenance in selected monophasic media
ES2074968B1 (es) Nuevas cepas de pseudomonas aeruginosa atenuadas.
Lacharme et al. Complete development of Cryptosporidium parvum in rabbit chondrocytes (VELI cells)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 381427

Country of ref document: ES